HLA-DR association in papillary thyroid carcinoma

Disease Markers

Volumn 28, Issue 1, 2010, Pages 49-53

  Amoli, Mahsa M ^a   Yazdani, Nasrin ^a   Amiri, Parvin ^a   Sayahzadeh, Forogh ^a   Haghpanah, Vahid ^a   Tavangar, Seyed Mohammad ^b   Amirzargar, Ali ^a   Ghaffari, Hamidollah ^a   Nikbin, Behrooz ^a   Larijani, Bagher ^a   Mostaan, Leila V ^a   Bazzaz, Javad Tavakkoly ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Genetics; HLA; Papillary carcinoma

Indexed keywords

HLA DR1 ANTIGEN;

ADULT; ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; HEREDITY; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; PAPILLARY CARCINOMA; POLYMERASE CHAIN REACTION; POPULATION; PRIORITY JOURNAL; THYROID CARCINOMA;

EID: 77249158820     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2010/130276     Document Type: Article

References (26)

1. L. Davies and H.G. Welch, Increasing incidence of thyroid cancer in the United States, 1973-2002, JAMA 10 (2006), 2164-2167.
2. T. Pal, F.D. Vogl, P.O. Chappuis, R. Tsang, J. Brierley, H. Renard, K. Sanders, T. Kantemiroff, S. Bagha, D.E. Goldgar, S.A. Narod andW.D. Foulkes, Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based study, J Clin Endocrinol Metab 86 (2001), 5307-5312.
3. J. Liska, V. Altanerova, S. Galbavy, S. Stvrtina and J. Brtko, Thyroid tumors: histological classification and genetic factors involved in the development of thyroid cancer, Endocr Regul 39 (2005), 73-83.
4. T. Porto, I. Coelho, J. Boavida, C. Pereira, J.M. Nunes, D. Mendonça, B. Martins, L.G. Sobrinho and V. Leite, Association of HLA DQ4-DR8 haplotype with papillary thyroid carcinomas, Clin Endocrinol (Oxf) 64 (2006), 179-183.
5. M. Browning and D. Dunnion, HLA and cancer: implications for cancer immunotherapy and vaccination, Eur J Immunogenet 24 (1997), 293-312. (Pubitemid 127746453)
6. F. Juhasz, L. Kozma, V. Stenszky, F. Gyory, G. Luckas and N.R. Farid,Well differentiated thyroid carcinoma is associated with human lymphocyte antigen D-related 11 in Eastern Hungarians: a case of changing circumstances, Cancer 15 (2005), 1603-1608.
7. F.Juhasz, P. Boros, G. Szegedi et al., Immunogenetic and immunologic studies of differentiated thyroid cancer, Cancer 63 (1989), 1318-1326.
8. F. Juhasz, G. Balazs, L. Kozma, E. Kraszits, V. Stenszky and N.R. Farid. Interaction of IgG heavy-chain allotypes (Gm) and HLA in conferring susceptibility to thyroid carcinoma, Clin Endocrinol (Oxford) 25 (1986), 17-21.
9. N. Panza, L. Del Vecchio, M. Maio et al, Strong association between an HLA-DR antigen and thyroid carcinoma, Tissue Antigens 20 (1982), 155-158.
10. V.Sridama, Y. Hara, R .Fauchet and L.J. DeGroot, Association of differentiated thyroid carcinoma with HLA-DR7, Cancer 56 (1985), 1086-1088.
11. F. Juhasz, G. Balazs, V. Stenszky, L. Kozma and N.R, Farid, The relation of susceptibility to and biologic behavior of thyroid epithelial cell cancer to HLA-DR1, Cancer 58 (1986), 52-54.
12. B. Larsen, C. Thompson, A. Kwan and N.R. Farid, Lack of association of HLA with thyroid cancer. An effect of iodine sufficiency and safe environment? Tissue Antigens 28 (1986), 298-300.
13. H. Dralle, M. Robin-Winn, L. Reilmann, A. Laue and M. Torok, HLA and thyroid cancer, Klin Wochenschr 64 (1986), 522-525.
14. M.Weissel, H. Kainz, R. Hoefer andW.R. Mayr, HLA-DR and differentiated thyroid cancer, Lack of association with the nonmedullary types and possible association with the medullary type, Cancer 62 (1988), 2486-2488.
15. S. Ahuja, I. Hoppe, H. von Keyserlingk and H. Ernst, HLAand thyroid carcinoma, Exp Clin Endocrinol 99 (1992), 134-136.
16. D. Rigopoulou, J. Martinez-Laso, F. Martinez-Tello et al., Both Class I and Class II HLA antigens are thyroid cancer susceptibility factors, Tissue Antigens 43 (1994), 281-285.
17. A. Rios, J.M. Rodriguez, M.R. Moya et al., Frequency of HLA-C alleles in differentiated thyroid carcinoma in southeastern Spain, Cancer 100 (2004), 264-269.
18. V. Haghpanah, K. Khalooghi, K. Adabi, P. Amiri, S.M. Tavangar, A. Amirzargar, H. Ghaffari, N. Yazdani, B. Nikbin, B. Larijani and M.M. Amoli, Associations between HLA-C alleles and papillary thyroid carcinoma, Cancer Biomark 5 (2009), 19-22.
19. A.K. Lancaster, R.M. Single, O.D. Solberg, M.P Nelson and G. Thomson, PyPop update - a software pipeline for largescale multilocus population genomics, Tissue Antigens 69 (2007), 192-197.
20. A. Dempster, N. Laird and D. Rubin, Maximum likelihood estimation from incomplete data using the EM algorithm, J R Stat Soc 39 (1977), 1-38.
21. L. Excoffier and M. Slatkin, Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population, Mol Biol Evol 12 (1995), 921-927.
22. P.W. Hedrick, Gametic disequilibriummeasures: proceed with caution, Genetics 117 (1987), 331-334.
23. H. Cramer, Mathematical Models of Statistics, Princeton, NJ: Princeton University Press, 1946.
24. E. Lindhorst, P.M. Schumm-Draeger, J. Bojunga, K.H. Usadel and G. Herrmann, Differences in tumor cell proliferation, HLA DR expression and lymphocytic infiltration in various types of thyroid carcinoma, Exp Clin Endocrinol Diabetes 110 (2002), 27-31.
25. A.P. Weetman, The genetics of autoimmune thyroid disease, Horm Metab Res 4 (2009), 421-425.
26. M.J. Simmonds, J.M. Howson, J.M. Heward, J. Carr-Smith, J.A. Franklyn, J.A. Todd and S.C. Gough, A novel and major association of HLA-C in Graves' disease that eclipses the classical HLA-DRB1 effect, Hum Mol Genet 16 (2007), 2149-2153.